All of the evidence provided on Hippocampome.org are quotes from scientific texts.
However, because quoted passages may be difficult to understand in isolation, contextual information and expanded abbreviations set in square brackets have been added for clarity.
Animal:
Protocol:
Expression:
Show:
Order:
EXPRESSION: negative (inference)
ANIMAL: rat
PROTOCOL: immunohistochemistry
Page location: p 559 left bottom
"We tested CR [calretinin] and CCK[cholecystokinin]-immunolabelling in VGLUT3[vesicular glutamate transporter type 3]-positive somata in the CA1 area. Somatic CCK- or CR- labelling occurred alone in 32.7% and 54.8% of the cells, respectively. There was no colocalization between CR and VGLUT3, or CR and CCK (Fig. 7B and Table 2). Likewise, none of the tested VGLUT3-positive cells in the CA3 area/dentate gyrus (123 cells) and isocortex (40 cells) was immunoreactive for CR."
Interpretation notes: Glutamatergic and GABAergic CCK+ types in CA1 SLM_SR_SP_SO are probably CR-; Clopper-Pearson confidence interval lower bound = 97.1% (n = 126/126)
EXPRESSION: negative (inference)
ANIMAL: rat
PROTOCOL: immunohistochemistry
Page location: p 559 left bottom
"We tested CR [calretinin] and CCK[cholecystokinin]-immunolabelling in VGLUT3[vesicular glutamate transporter type 3]-positive somata in the CA1 area. Somatic CCK- or CR- labelling occurred alone in 32.7% and 54.8% of the cells, respectively. There was no colocalization between CR and VGLUT3, or CR and CCK (Fig. 7B and Table 2). Likewise, none of the tested VGLUT3-positive cells in the CA3 area/dentate gyrus (123 cells) and isocortex (40 cells) was immunoreactive for CR."
Interpretation notes: Glutamatergic and GABAergic CCK+ types in CA1 SLM_SR_SP_SO are probably CR- by contrapositive logic
Browse
Search
Help
negative; confirmed by inference(s)